Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Aug;54(2):494–499. doi: 10.1172/JCI107785

Thyroid-Stimulating Activity and Chorionic Gonadotropin

Bruce C Nisula 1, Jean-Marie Ketelslegers 1
PMCID: PMC301577  PMID: 4136227

Abstract

The nature of the substance with thyroid-stimulating activity (TSA) present in human chorionic gonadotropin (hCG) prepared from pregnancy urine was investigated. In the mouse thyrotropin bioassay, the characteristic maximum of blood radioactivity obtained with the TSA in hCG preparations occurred after that obtained with pituitary thyrotropin (hTSH) but before that obtained with long-acting thyroid stimulator. Antiserum to the α subunit of hCG produced significant neutralization of the TSA in hCG. Significant antagonism of hTSH biologic activity was achieved with certain doses of hCG, suggesting that the TSA in hCG was a partial agonist of hTSH. This antagonism was neutralized by antiserum to the β subunit of hCG. These immunologic results suggest that the substance with TSA in hCG preparations contains antigenic determinants similar to those of both the α and the β subunit of hCG. Amounts of highly purified hCG and crude commercial hCG of equal immunologic activity were biologically indistinguishable in the bioassay for TSA. Both hCG immunoreactivity and the TSA in hCG adsorbed to concanavalin A and eluted with 0.2 M methyl α-D-glucopyranoside. These results are consistent with the hypothesis that TSA is an intrinsic property of hCG or of a glycoprotein molecule physicochemically, biologically, and immunologically similar to hCG.

Full text

PDF
494

Images in this article

496Image
on p.496
497Image
on p.497
497Image
on p.497

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AKASU F., KAWAHARA S., OHKI H., HARANO M., TEJIMA Y. Thyroid stimulating hormone extracted from human placenta. Endocrinol Jpn. 1955 Dec;2(4):297–302. doi: 10.1507/endocrj1954.2.297. [DOI] [PubMed] [Google Scholar]
  2. Ashitaka Y., Mochizuki M., Tojo S. Purification and properties of chorionic gonadotropin from the trophoblastic tissue of hydatidiform mole. Endocrinology. 1972 Mar;90(3):609–617. doi: 10.1210/endo-90-3-609. [DOI] [PubMed] [Google Scholar]
  3. Aspberg K., Porath J. Group-specific adsorption of glycoproteins. Acta Chem Scand. 1970;24(5):1839–1841. doi: 10.3891/acta.chem.scand.24-1839. [DOI] [PubMed] [Google Scholar]
  4. Burger A. Studies on a thyroid stimulating factor in urinary chorionic gonadotrophin preparations. Acta Endocrinol (Copenh) 1967 Aug;55(4):587–599. doi: 10.1530/acta.0.0550587. [DOI] [PubMed] [Google Scholar]
  5. Canfield R. E., Morgan F. J., Kammerman S., Bell J. J., Agosto G. M. Studies of human chorionic gonadotropin. Recent Prog Horm Res. 1971;27:121–164. doi: 10.1016/b978-0-12-571127-2.50028-6. [DOI] [PubMed] [Google Scholar]
  6. Cohen J. D., Utiger R. D. Metastatic choriocarcinoma associated with hyperthyroidism. J Clin Endocrinol Metab. 1970 Apr;30(4):423–429. doi: 10.1210/jcem-30-4-423. [DOI] [PubMed] [Google Scholar]
  7. DOWLING J. T., INGBAR S. H., FREINKEL N. Iodine metabolism in hydatidiform mole and choriocarcinoma. J Clin Endocrinol Metab. 1960 Jan;20:1–12. doi: 10.1210/jcem-20-1-1. [DOI] [PubMed] [Google Scholar]
  8. Dufau M. L., Tsuruhara T., Catt K. J. Interaction of glycoprotein hormones with agarose-concanavalin A. Biochim Biophys Acta. 1972 Sep 29;278(2):281–292. doi: 10.1016/0005-2795(72)90233-4. [DOI] [PubMed] [Google Scholar]
  9. Galton V. A., Inggar S. H., Jimenez-Fonseca J., Hershman J. M. Alterations in thyroid hormone economy in patients with hydatidiform mole. J Clin Invest. 1971 Jun;50(6):1345–1354. doi: 10.1172/JCI106614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hennen G. Detection and study of a human-chorionic-thyroid-stimulating factor. Arch Int Physiol Biochim. 1965 Sep;73(4):689–695. doi: 10.3109/13813456509084890. [DOI] [PubMed] [Google Scholar]
  11. Hennen G., Pierce J. G., Freychet P. Human chorionic thyrotropin: further characterization and study of its secretion during pregnancy. J Clin Endocrinol Metab. 1969 Apr;29(4):581–594. doi: 10.1210/jcem-29-4-581. [DOI] [PubMed] [Google Scholar]
  12. Hershman J. M., Higgins H. P. Hydatidiform mole--a cause of clinical hyperthyroidism. Report of two cases with evidence that the molar tissue secreted a thyroid stimulator. N Engl J Med. 1971 Mar 18;284(11):573–577. doi: 10.1056/NEJM197103182841103. [DOI] [PubMed] [Google Scholar]
  13. Hershman J. M. Hyperthyroidism induced by trophoblastic thyrotropin. Mayo Clin Proc. 1972 Dec;47(12):913–918. [PubMed] [Google Scholar]
  14. Hershman J. M., Starnes W. R. Extraction and characterization of a thyrotropic material from the human placenta. J Clin Invest. 1969 May;48(5):923–929. doi: 10.1172/JCI106051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hershman J. M., Starnes W. R. Placental content and characterization of human chorionic thyrotropin. J Clin Endocrinol Metab. 1971 Jan;32(1):52–58. doi: 10.1210/jcem-32-1-52. [DOI] [PubMed] [Google Scholar]
  16. Karp P. J., Hershman J. M., Richmond S., Goldstein D. P., Selenkow H. A. Thyrotoxicosis from molar thyrotropin. Arch Intern Med. 1973 Sep;132(3):432–436. [PubMed] [Google Scholar]
  17. LYON R. A., SIMPSON M. E., EVANS H. M. Qualitative changes in urinary gonadotrophins in human pregnancy during the period of rapid increase in hormone titer. Endocrinology. 1953 Dec;53(6):674–686. doi: 10.1210/endo-53-6-674. [DOI] [PubMed] [Google Scholar]
  18. Nisula B. C., Kohler P. O., Vaitukaitis J. L., Hershman J. M., Ross G. T. Neutralization of human thyrotropin by antisera to subunits of glycoprotein hormones. J Clin Endocrinol Metab. 1973 Nov;37(5):664–669. doi: 10.1210/jcem-37-5-664. [DOI] [PubMed] [Google Scholar]
  19. ODELL W. D., BATES R. W., RIVLIN R. S., LIPSETT M. B., HERTZ R. Increased thyroid function without clinical hyperthyroidism in patients with choriocarcinoma. J Clin Endocrinol Metab. 1963 Jul;23:658–664. doi: 10.1210/jcem-23-7-658. [DOI] [PubMed] [Google Scholar]
  20. REISFELD R. A., LEWIS U. J., BRINK N. G., STEELMAN S. L. Human growth hormone: preparation from acetone powder. Endocrinology. 1962 Oct;71:559–563. doi: 10.1210/endo-71-4-559. [DOI] [PubMed] [Google Scholar]
  21. RUDINGER J., KREJCI I. Dose-response relations for some synthetic analogues of oxytocin, and the mode of action of oxytocin on the isolated uterus. Experientia. 1962 Dec 15;18:585–588. doi: 10.1007/BF02172197. [DOI] [PubMed] [Google Scholar]
  22. Rayford P. L., Vaitukaitis J. L., Ross G. T., Morgan F. J., Canfield R. E. Use of specific antisera to characterize biologic activity of hCG-beta subunit preparations. Endocrinology. 1972 Jul;91(1):144–146. doi: 10.1210/endo-91-1-144. [DOI] [PubMed] [Google Scholar]
  23. STEIGBIGEL N. H., OPPENHEIM J. J., FISHMAN L. M., CARBONE P. P. METASTATIC EMBRYONAL CARCINOMA OF THE TESTIS ASSOCIATED WITH ELEVATED PLASMA TSH-LIKE ACTIVITY AND HYPERTHYROIDISM. N Engl J Med. 1964 Aug 13;271:345–349. doi: 10.1056/NEJM196408132710704. [DOI] [PubMed] [Google Scholar]
  24. Seelig S., Kumar S., Sayers G. Isolated adrenal cells: the partial agonists (Trp(Nps) 9 )ACTH 1-39 and (Trp(Nps) 9 )ACTH 1-24 (nitrophenyl sulfenyl derivatives of ACTH). Proc Soc Exp Biol Med. 1972 Apr;139(4):1217–1219. doi: 10.3181/00379727-139-36332. [DOI] [PubMed] [Google Scholar]
  25. Vaitukaitis J. L., Ross G. T. Recent advances in evaluation of gonadotropic hormones. Annu Rev Med. 1973;24:295–302. doi: 10.1146/annurev.me.24.020173.001455. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES